May 29, 2026 Biotech’s Crisis: How Distrust, Politics, and Short-Term Investing Threaten America’s Scientific Leadership
April 18, 2026 Revolution Medicines’ Daraxonrasib Doubles Survival in Pancreatic Cancer Phase 3 Trial
